CIK: 0001910456 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $115,635 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CABA | CABALETTA BIO INC | 2,825,976 | $26,140 | 22.6% | $3.64 | 0.0% | COM | 12674W109 |
| — | ALPINE IMMUNE SCIENCES INC | 3,126,173 | $22,977 | 19.9% | $10.20 | — | COM | 02083G100 |
| — | MERUS N V | 854,591 | $13,221 | 11.4% | $26.06 | — | COM | N5749R100 |
| — | KINNATE BIOPHARMA INC | 1,998,417 | $12,190 | 10.5% | $11.09 | — | COM | 49705R105 |
| — | CYMABAY THERAPEUTICS INC | 1,653,495 | $10,367 | 9.0% | $3.16 | — | COM | 23257D103 |
| — | BELLUS HEALTH INC NEW | 1,093,900 | $8,992 | 7.8% | $7.70 | — | COM NEW | 07987C204 |
| — | PIERIS PHARMACEUTICALS INC | 5,628,585 | $5,854 | 5.1% | $1.81 | — | COM | 720795103 |
| — | PARDES BIOSCIENCES INC | 3,003,102 | $5,075 | 4.4% | $6.19 | — | COM | 69945Q105 |
| — | PASSAGE BIO INC | 3,355,917 | $4,631 | 4.0% | $1.44 | — | COM | 702712100 |
| — | THESEUS PHARMACEUTICALS INC | 784,158 | $3,905 | 3.4% | $8.59 | — | COM | 88369M101 |
| — | NEOLEUKIN THERAPEUTICS INC | 2,291,133 | $1,166 | 1.0% | $0.51 | — | COM | 64049K104 |
| WHWK | AADI BIOSCIENCE INC | 64,739 | $831 | 0.7% | $13.06 | 0.0% | COM | 00032Q104 |
| PHVS | PHARVARIS N V | 25,325 | $285 | 0.2% | $5.25 | 0.0% | COM | N69605108 |